title: An exceptional case of atrial fibrillation arrhythmia induced by etoposide.
abstract: BACKGROUND
  Arrhythmia induced by etoposide is exceedingly rare. There are only a very few individual case histories of arrhythmias during etoposide infusion, including atrial fibrillation.
  
  
  OBJECTIVE
  Through this uncommon case, we propose to study the pathophysiology, the diagnosis and the management of this entity.
  
  
  METHODS
  We report a case of a 57-year-old man, without cardiac history, followed for endocrine tumor of the pancreas with liver metastases who had presented atrial fibrillation (AF) after etoposide infusion.
  
  
  CONCLUSIONS
  It is important to consider cardiac monitoring during etoposide infusion in patients with known cardiac disease or at high risk of cardiac complications.
authors: Department of Oncology, Habib Bourguiba Hospital Sfax 3029, Tunisia. walabenkridis@yahoo.fr.
authors: Wala Ben
authors: WB
authors: Kridis
authors: Afef
authors: A
authors: Khanfir
authors: Faten
authors: F
authors: Triki
authors: Mounir
authors: M
authors: Frikha
mesh_terms: D000972:Antineoplastic Agents, Phytogenic / Q000009:adverse effects* / Q000627:therapeutic use; D001281:Atrial Fibrillation / Q000139:chemically induced* / Q000175:diagnosis / Q000503:physiopathology; D016903:Drug Monitoring / Q000379:methods; D005047:Etoposide / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D008113:Liver Neoplasms / Q000188:drug therapy / Q000556:secondary; D008297:Male; D008875:Middle Aged; D010190:Pancreatic Neoplasms / Q000188:drug therapy / Q000473:pathology
chemical_list: D000972:Antineoplastic Agents, Phytogenic; D005047:Etoposide